期刊
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
卷 81, 期 4, 页码 291-301出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.plefa.2009.05.026
关键词
NADA; Dopamine; TH; FAAH; Biosynthesis
资金
- NIDA NIH HHS [DA13012, R01 DA018224-04, K05 DA021696, R01 DA018224, R01 DA013012] Funding Source: Medline
N-arachidonoyl dopamine (NADA) is an endogenous ligand that activates the cannabinoid type I receptor and the transient receptor potential vanilloid type I channel. Two potential biosynthetic pathways for NADA have been proposed, though no conclusive evidence exists for either. The first is the direct conjugation of arachidonic acid with dopamine and the other is via metabolism of a putative N-arachidonoyl tyrosine (NA-tyrosine). In the present study we investigated these biosynthetic mechanisms and report that NADA synthesis requires TH in dopaminergic terminals; however, NA-tyrosine, which we identify here as an endogenous lipid, is not an intermediate. We show that NADA biosynthesis primarily occurs through an enzyme-mediated conjugation of arachidonic acid with dopamine. While this conjugation likely involves a complex of enzymes, our data suggest a direct involvement of fatty acid amide hydrolase in NADA biosynthesis either as a rate-limiting enzyme that liberates arachidonic acid from AEA, or as a conjugation enzyme, or both. Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据